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Abstract
Three experiments examined the effects of drug-extinction when a drug state served as a conditional
stimulus (CS) for sucrose delivery or as a positive feature for pairings between a discrete CS (e.g.,
15-s light-on) and sucrose. Some conditioning models predict that drug-state will facilitate the
conditional response (CR) based on an association with sucrose whether the drug is trained as a CS
or as a facilitator. If so, repeated presentation of the drug state alone (drug-extinction) should decrease
the CR in both situations. Nicotine (0.4 mg/kg), amphetamine (AMP, 1 mg/kg), and chlordiazepoxide
(CDP, 5 mg/kg) facilitated a goal-tracking conditioned response to the discrete CS; however, AMP
and CDP did not evoke reliable responding without an interposed stimulus, suggesting that
associations between these drug states and sucrose are not expressed as anticipatory food-seeking
(goal tracking). Repeated presentation of each drug state alone did not disrupt facilitation by nicotine,
amphetamine, or CDP; suggesting that the drug states did not facilitate goal tracking based on a direct
association with sucrose. This latter finding implicates a higher-order or non-associative mechanism
for facilitation of anticipatory food-seeking by drug-states in this Pavlovian discrimination task.
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Introduction
Drug dependence disorders are chronic relapsing conditions that are characterized by
inappropriate drug-seeking and drug-taking in the face of negative social and behavioral
consequences [1]. Most current models of drug addiction take into account the well-established
link between drug-associated environmental cues and drug-seeking behaviors (e.g., [3,14,21,
37]). Some of these models assign non-drug stimuli a central role, arguing that association with
the drug distorts their value and their subsequent control over behavior becomes perseverative
and intransigent [14,37]. Unfortunately, cessation therapies that strive to break the relationship
between the drug and non-drug stimulus (cue-exposure or extinction therapies) have not proven
to be more successful than other treatments [12]. One reason could be that there are many
associative learning phenomena which represent ‘threats to extinction’ (renewal, spontaneous
recovery, reinstatement, and discriminative stimuli; see [12]). For example, extinction of
nicotine-related cues in smokers (e.g., viewing lit cigarettes and ashtrays) may not account for
all of the nicotine-predictive stimuli in a person’s repertoire. Conklin and Tiffany [12] and
Troisi [46] argue that a number of other stimuli (contextual, sensorimotor, etc.), will retain
their excitatory value and could facilitate future drug taking if untargeted by exposure therapy.
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We have previously argued that Pavlovian occasion setters offer a particularly important threat
to extinction and exposure therapy for addictions [5]. This argument is due in part to the ability
of occasion setters to transfer their control to circumstances in which they have never previously
occurred. To use an anecdotal example, the stimulus effects of alcohol (a feature) could set the
occasion for a person (a target conditional stimulus, or CS), to be associated with cigarette
smoking and nicotine delivery (unconditional stimulus or US). If this person were a co-worker
they may be viewed in the absence of alcohol and smoking would presumably occur with more
rarity. Similarly, the stimulus effects of alcohol may be present without the person, and smoking
may occur less often. Both stimuli are partially associated with smoking, but alcohol sets the
occasion upon which the person-CS and smoking co-occur. What if alcohol is present when
another smoking-related stimulus occurs (e.g., features of a bar, lit cigarette in an ashtray, etc.)?
Would alcohol increase the probability of smoking? One feature of “occasion setters” is that
they are able to transfer their conditional control to novel situations [8,18,19,25,32,33,34,43,
44], thus the alcohol feature may facilitate or increase the probability of goal seeking— i.e.,
acquiring and smoking a cigarette in this example.
Another striking property of occasion setters is that they continue to control behavior even
when their associative status is altered. For example, the transfer of conditional control
described in the previous paragraph is easy to explain if both the feature (alcohol) and the CS
(person) are directly associated with the US (the effects of nicotine) [31]. In the presence of
an alternate tobacco related CS (bar), the tobacco-seeking conditional response (CR) is stronger
because there are two tobacco-related stimuli (alcohol and bar). However, direct associations
between features and the US are not always needed. For example, repeated presentation of a
positive feature alone (i.e., procedural extinction), should decrease its ability to strengthen the
CR. However, depending on the circumstances, this extinction treatment may not decrease a
feature’s ability to facilitate responding [44]. Thus, occasion setters are fluid, or functional in
their control over responding. In order for a feature to be fully extinguished of facilitative
control, it must be presented along with the original CS and without the US [23]. Returning to
the preceding example, if our subject wanted to successfully quit smoking with an exposure
treatment, then both the person-CS and alcohol would need to be presented without access to
the tobacco product.
Although many discrete and contextual stimuli have served as occasion setters in previous
studies, research with drug-induced contexts has been more limited. This is somewhat
surprising due to the contextual nature of drug states. In contrast to discrete stimuli, a drug
state turns ‘on’ and ‘off’ rather slowly, stays on for extended periods which are longer or shorter
depending on pharmacology, and has multimodal biological impact. We have argued that this
aspect of drug stimuli makes them particularly relevant as modulators of associative learning
[5]. Drug-induced contexts can have a discriminative influence on the acquisition/expression
of learning in both Pavlovian and operant conditioning paradigms (e.g., [17,22,38,42,45,46,
48)]. In the most widely studied Pavlovian preparation, drug states set the occasion on which
a novel flavor (CS, typically saccharin) will be followed by an aversive outcome (US, typically
lithium chloride injection, e.g., [20,22,30,40,41]). Subjects learn to avoid the taste solution in
the proper drug state. Similar to traditional occasion setting situations, discriminated avoidance
of the taste does not depend on an association between the drug state and lithium [22,41].
Moreover, rats will avoid familiar and novel tastants when they are presented in a drug state
that has previously set the occasion for a saccharin-lithium pairing [40]. Skinner and colleagues
[40,41] have suggested that this transfer is analogous to that described with traditional occasion
setting features [8,19,43].
Recent experiments from our laboratory have extended the study of drug contexts to appetitive
conditioning situations and to nicotine, amphetamine, and chlordiazepoxide (CDP) drug states
([27,28,39]; see [24,29] for similar studies with pigeons and opiate drugs). Briefly, in the drug
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state (e.g., 0.4 mg/kg nicotine injected 5-min before the session) a discrete CS (15-s stimulus
light illumination) was repeatedly paired with sucrose. In the non-drug state (vehicle injected
before the session) the same CS was not followed by any scheduled outcome. The CS evoked
anticipatory food-seeking (i.e., goal tracking) in a manner that was specific to the drug state.
Initial studies investigated the relationship between drug dose and magnitude of the conditional
response [27,28]. Maximal goal tracking was evoked at the training dose (e.g., 0.4 mg/kg
nicotine, 1 mg/kg amphetamine, 5 mg/kg CDP) and decreasing each drug’s dose decreased the
rate of goal tracking. Also, drugs from different pharmacological classes (i.e., stimulants and
anxiolytics) did not substitute for one another [28]. Finally, anticipatory food-seeking was
evoked in the drug state by both visual (i.e., light-on) and auditory (i.e., white noise-on)
conditional stimuli [28].
The present studies sought to determine whether nicotine, amphetamine, and CDP functioned
as occasion setters. These particular drugs were chosen because their dose-response and
substitution profiles were already described. Subsequent studies [26] determined whether they
transferred conditional control to novel situations. However, before transfer of occasion setting
could be interpreted, we had to determine whether facilitated responding was the result of direct
drug-US associations. For example, nicotine can serve as a conditional stimulus for sucrose
(i.e., the drug-state evokes goal tracking, see [4,47]) as well as a positive feature for CS-sucrose
pairings [27,28]. Thus, the latter may be attributed to a direct association between the drug and
sucrose; facilitated goal tracking depending on presenting two conditional stimuli (the drug
state and the CS [31]). Currently, no study has addressed whether drug states trained as
facilitators [27,28] increase responding because the drug is associated with the sucrose US
[31], or because the drug state acquires discriminant properties that do not depend on its
excitatory strength [e.g., serve as occasion setters, 43]. Given that repeated presentation of a
drug feature alone (i.e., drug-extinction) attenuates drug-evoked goal tracking [4], if facilitation
is based on a direct association with sucrose, then a drug extinction procedure should decrease
the facilitative effect. Experiment 1 examined the effects of a drug extinction procedure after
nicotine was explicitly trained as a CS (paired with sucrose) or as a positive feature/facilitator
(set the occasion for CS-sucrose pairings). Experiments 2A and 2B made similar
determinations for amphetamine and CDP.
Method
Subjects
Seventy-four male Sprague Dawley rats from Harlan (Indianapolis, IN) were housed
individually in clear plastic tubs lined with wood-shavings in a temperature- and humidity-
controlled colony. Access to food was restricted such that rats were maintained at 85% of their
free-feeding weight [Mean (STD)=382 (22) g]. This target bodyweight was increased by 2 g
every 28 days; water was available continuously in the home cage. Experimental sessions were
conducted on consecutive days during the light portion of a 12 h light:dark cycle. All procedures
were approved by the University of Nebraska-Lincoln IACUC and followed the “Principles
of laboratory animal care” (NIH publication No. 85-23, revised 1985).
Apparatus
Experiments were conducted in seven standard conditioning chambers (ENV-008CT; Med
Associates, Georgia VT) housed in a sound-attenuating cubicle (ENV-018). Each chamber had
a Plexiglas ceiling and front and back walls with two aluminum sidewalls; all stimulus elements
were attached to the aluminum walls. One side of each chamber was fitted with a liquid dipper
in a receptacle (5.2 x 5.2x 3.8 cm; l x w x d); the dipper had a 0.1-ml cup attached for sucrose
delivery. The receptacle was fitted with an infrared emitter/detector unit to monitor head
entries. On the same wall were two white stimulus lights (100 mA), these lights were mounted
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above and to the side of the receptacle and served as the light CS. A speaker and amplifier unit
that provided the white noise CS (70 dB) was mounted to the upper back corner of the opposite
wall. A personal computer with Med Associates interface and software controlled the stimulus
events and recorded dipper entries throughout each session.
Drugs
(-)-Nicotine hydrogen tartrate (Sigma, St Louis, MO) was dissolved in physiological saline,
brought to a pH of 7.0 ± 0.2 with a dilute NaOH solution, and injected subcutaneously (SC) at
1 ml/kg. D-amphetamine sulfate and chlordiazepoxide hydrochloride (Sigma, St Louis, MO)
were dissolved in physiological saline and injected intraperitoneally (IP) at 1 ml/kg. Nicotine
doses are expressed as the base form; other drug doses are expressed as the salt form.
General Procedure
Dipper Training—In the first three sessions rats were trained to drink 26% sucrose (w/v)
within 4 s. Sucrose was delivered according to a probability function with a value of 0.167 per
4 s. This function resulted in sucrose delivery on approximately 16.7% of the 4 s intervals
during a 50-min session, or about 1 sucrose presentation every 6 intervals (24 s). Across three
dipper training sessions the probability function was gradually decreased to 5% (1 sucrose
presentation per 120 s). Robust dipper entry behavior was evident for all rats by the end of day
3.
Discrimination Training—Rats assigned to the “Drug-Feature” conditions received 8
presentations of a 15-s CS (white noise or light) during each session. On drug sessions (0.4
mg/kg nicotine, 1 mg/kg amphetamine IP, or 5 mg/kg CDP injected before the session), each
CS presentation was followed immediately by 4-s access to sucrose. On saline sessions 0.9%
NaCl was injected before the session and CS presentations were not followed by any outcome.
Rats assigned to the “Drug-CS” conditions did not receive the white noise or light during the
experiment. Rather, on drug sessions, they received 8 unsignaled presentations of the 4-s
sucrose US. During saline sessions there were no scheduled events. For both Drug-Feature and
Drug-CS conditions, no sucrose occurred during saline sessions, instead a 4-s “empty interval”
replaced sucrose to equate data sampling across the sessions.
Discrimination Training was separated into 8-day cycles during which each rat received 4 drug
and 4 saline sessions in quasi-random order. The cycles were constructed such that the same
session type (drug or saline) did not occur on more than 2 consecutive days. Each session was
controlled by one of 4 Med-State Notation (Med Associates, Georgia VT) programs which
varied the first CS onset, US onset, and the order of inter-trial intervals (ITIs). Varying these
intervals within and across trials made CS/US onset less predictable. For rats in the Drug-
Feature conditions, ITIs were defined as the time from CS offset to the next CS onset
(mean=154 s, range=94-214 s), the first CS occurred on average 120 s after the session began
(range=75-165 s). For rats in the Drug-CS condition, ITIs were defined as the time from US
offset to next US onset (mean=141 s, range=90-210 s), the first US occurred on average 120
s after the session began (range=90-150 s). The marginal interval differences between the two
conditions were driven by differences between events during the session (e.g., 15 s CS vs.
unsignaled US) and the manner in which programs were constructed to sample data. Unless
otherwise noted, rats in each condition received 40 training sessions; 20 preceded by drug and
20 preceded by saline.
Drug Extinction—In each drug-extinction experiment, 20 sessions were included to ensure
that any anticipatory food seeking evoked by the drug had been abolished. Because of the long
interval between training and testing (20 days) positive control groups determined whether the
drug states retained the ability to evoke or facilitate anticipatory food-seeking after this
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extended retention-interval. Unless otherwise noted, rats in each condition (Drug-Feature or
Drug-CS) were randomly assigned to one of two extinction treatment groups [EXT (i.e., drug-
extinction) or RET (i.e., retention-interval)] with the constraint that conditional responding
during the training phase did not differ across groups. For rats in the Drug-Feature conditions,
this assignment was further constrained by balancing of CS modality. The Drug Extinction
phase consisted of 20 consecutive sessions in which no stimuli were presented (i.e., white noise,
light, or sucrose). Rats in the EXT groups received drug injections before each session. Rats
in the RET groups received saline injections before each session. All other parameters were
identical to Discrimination Training, except that dipper entries were recorded in 30-s intervals
across each session for all rats.
Post-Extinction Tests—Unless otherwise noted, the effect of drug extinction was tested in
two 20-min sessions which occurred on consecutive days. For all rats, one of these sessions
occurred after drug injection; the other occurred after saline injection. In each condition (Drug-
Feature or Drug-CS), the test order (drug or saline) was counterbalanced for group (EXT or
RET) and CS modality (white noise or light) where appropriate. For rats in the Drug-Feature
condition, each test contained 3 presentations of the discrete cue from Discrimination Training.
No stimuli were presented during the test sessions for rats in the Drug-CS condition.
Specific Experiments
Experiment 1—Following dipper training, rats were randomly assigned to one of 2
conditions: Nicotine-Feature, n=16 or Nicotine-CS, n=14. For both conditions nicotine (0.4
mg/kg) or saline injections were administered 5 min before each session.
Experiment 2A—Following dipper training, rats in the both groups (AMP, n=7 or CDP, n=5)
underwent discrimination training in which one of the drugs served as a putative CS for sucrose
(Drug-CS conditions). For the AMP group, amphetamine (1 mg/kg) or saline was injected 15-
min before each session. For the CDP group, CDP (5 mg/kg) or saline was injected 15-min
before each session. Discrimination Training was originally scheduled to be conducted in 5
eight-day cycles (40 sessions). However at the end of the 5 cycle, the data pattern suggested
that additional training might result in a more reliable CR. Therefore, two additional training
cycles were added. Extinction and test phases were not included based on the pattern of goal
tracking at the end of the acquisition phase (see Results).
Experiment 2B—Following dipper training, rats in the both groups (AMP, n=16 or CDP,
n=16) underwent discrimination training in which one of the drugs served as positive feature
for CS-sucrose pairings (Drug-Feature conditions). Amphetamine (1 mg/kg), CDP (5 mg/kg),
or saline was injected 15-min before each session. During the training phase, one AMP rat
trained with the white noise CS was mistakenly switched to the light CS for 8 sessions (i.e., 1
cycle). The rat was dropped from the experiment and its data were eliminated from figures and
analyses. During Discrimination Training, the experimenter (MIP) observed that rats receiving
CDP and the white noise CS appeared to be making “maintained head-poke” responses during
the CS. As a result, the interface equipment and programs were altered to allow collection of
both frequency and duration of dipper entries. Duration data was acquired by generating a
“count” for every interrupt request (10-ms resolution) that the dipper receptacle beam was
broken. Beginning on session 12, dipper entry durations were recorded and converted to
seconds; pre-CS durations were subtracted from CS durations to produce what will hereafter
be referred to as a “duration score”. This measure was chosen because it is an analog of the
elevation score (see later). During the drug extinction phase the proportion of time that the
dipper receptacle beam was broken during the first 2-min of each session was calculated as an
analog of the dipper entry rate score.
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Dependent Measures & Data Analyses
Drug-Feature Conditions—Elevation scores were calculated as dipper entries that
occurred during the 15 s CS minus dipper entries that occurred during the 15 s before CS onset
[9].Average elevation scores for each session served as the main dependent measure. An
elevation score of 0 indicates equal goal tracking during the CS and pre-CS periods across a
session; positive elevation scores indicate more goal tracking during the CS. For
Discrimination Training, three-way mixed factors analysis of variance (ANOVA) compared
mean elevation scores across Drug (nicotine vs. saline), CS (light vs. white noise), and Session
(1-20). For the Post-Extinction Test, a three-way mixed factors ANOVA compared mean
elevation scores across Drug (nicotine vs. saline), Group (EXT vs. RET), and Trial (1-3).
Drug-CS Conditions—The main dependent measure was the number of dipper entries that
occurred before the first 4-s sucrose delivery (nicotine sessions) or 4-s empty interval (saline
sessions). This frequency score was converted to dipper entry rate to equate for the varying
time to first US onset across sessions (see Procedures). For Discrimination Training, two-way
repeated measures ANOVA compared dipper entry rate across Drug (nicotine vs. saline) and
Session (1-20). For the Post-Extinction Test, two-way mixed factors ANOVA compared dipper
entry rate across Drug (nicotine vs. saline) and Group (EXT vs. RET).
Drug Extinction—During the Drug Extinction phase no stimuli were presented. Therefore,
the dipper entry rate from the first 2 min of each session was calculated for both conditions
(Feature and CS) because this was the main dependent measure of nicotine-evoked conditional
responding during Discrimination Training. Since the treatments and measures were identical
across conditions during Drug Extinction, a three-way mixed factors ANOVA compared dipper
entry rate for Group (EXT vs. RET), Condition (Feature vs. CS), and Session (1-20). For each
phase and/or condition, significant interactions were followed up by paired or independent
samples t-tests contrasting across Drug or Group, respectively. Statistical significance was set
a priori at p≤0.05 (two-tailed) for all statistical analyses.
Results
Experiment 1
Discrimination Training—A stimulus paired with sucrose in the nicotine state, but not in
the saline state, evoked nicotine-specific goal tracking (Figure 1A). Omnibus three-way
ANOVA revealed that all main effects and interactions were significant, Fs≥4.31, ps<0.001,
except for the Drug x CS interaction, F<1. More goal tracking during the white noise, relative
to the light, was evident on both nicotine and saline sessions during the initial training sessions.
Independent samples t-tests with Bonferroni’s correction (calculated p*20 comparisons)
contrasted CS modality (white noise vs. light) for each Drug (nicotine or saline) to further
investigate the Drug x CS x Session interaction. For nicotine sessions, rats trained with the
white noise CS had higher mean elevation scores than rats trained with the light CS from
Sessions 3-6, ts(14)≥4.16, ps≤0.04. A similar pattern was revealed across saline sessions; rats
trained with the white noise CS had higher mean elevation scores than rats trained with the
light CS on session 2, t(14)=3.26, p=0.04.
The pharmacological effects of nicotine evoke a goal tracking CR when paired with intermittent
sucrose presentation (CS Condition; Figure 1B). The ANOVA revealed significant main effects
of Drug, F(1,247)=27.45, p<0.001, and Session, F(19,247)=9.66, p<0.001, and a significant
Drug x Session interaction, F(19,247)=27.42, p<0.001. Goal tracking rate was lower on the
first nicotine session relative to the first saline session, t(13)≥13.17, corrected p=0.01. On
Sessions 5, 6, and 9-20, dipper entry rates on nicotine sessions were higher than respective
saline sessions, ts(13)≥4.26, corrected ps≤0.02. This pattern is consistent with psychomotor
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suppression induced by acute nicotine treatment, followed by hyperactivity and/or acquisition
of a nicotine-specific CR after chronic treatment (see Drug Extinction).
Drug Extinction—EXT groups in both conditions initially displayed more goal tracking than
RET groups; this difference decreased across Drug Extinction sessions. Omnibus ANOVA
revealed significant main effects of Session, F(19,494)=6.72, p<0.001, of Group, F(1,26)
=12.28, p<0.01, and a significant Group x Session interaction, F(19,494)=2.40, p<0.01. The
main effects and interactions that included the Condition factor (Drug-Feature vs. Drug-CS)
were not significant, Fs<1. Corrected (calculated p*20 comparisons) independent samples t-
tests compared dipper entry rates from each session for Feature or CS conditions. For rats in
the Feature condition, the EXT group had significantly higher dipper entry rates than the RET
group on Drug Extinction sessions 1 and 13, ts(14)≥4.33, ps≤0.02. For rats in the CS condition,
the EXT group had higher dipper entry rates than the RET group on Sessions 1-2, ts(12) ≥4.02,
ps≤0.04. Because the nicotine-evoked goal tracking CR was extinguished after repeated
nicotine-alone treatment, the CR cannot be explained by drug-induced hyperactivity (Figures
1C & 1D).
Post-Extinction Tests—Facilitation of conditioned responding by nicotine does not depend
on nicotine-evoked goal tracking (Figure 2A). The three-way ANOVA revealed a significant
main effect of Drug, F(1,28)=41.84, p<0.001, a significant Drug x Group interaction, F(1,28)
=4.74, p<0.01, and a significant Drug x Trial interaction, F(2,28)=3.82, p<0.01. No other main
effects or interactions were significant, Fs<1. Rats in the RET group had lower elevation scores
on the nicotine test and higher elevation scores on the saline test. We would not expect this
pattern if nicotine was, in fact, a partially extinguished conditioned excitor in the EXT group.
For the EXT group (Figure 2A), elevation scores on the nicotine session were significantly
higher than the saline session for all 3 trials, ts(7) ≥2.35, ps≤0.050. For the RET group, elevation
scores on the nicotine session differed from saline session scores on trials 1 and 3, ts(7)≥2.52,
ps≤0.040.
On the Post-Extinction Tests, repeated presentation of nicotine attenuated the goal tracking
CR previously evoked by nicotine; repeated saline injections did not alter the conditional
response (Figure 2B). The two-way ANOVA on dipper entry rate revealed significant main
effects of Group, F(1,12)=27.92, p<0.001, and of Drug, F(1,12)=56.31, p<0.001, as well as a
significant Group x Drug interaction, F(1,12)=41.21, p<0.001. For the RET group, dipper entry
rate was higher on the nicotine test, relative to the saline test, t(6)=10.29, p<0.001. However,
dipper entry rate for the EXT group did not differ across test sessions, t<1.
Experiment 2A
Discrimination Training—Amphetamine evoked weak and unreliable goal-tracking as the
result of repeated pairing with sucrose (Figure 3A). Omnibus two-way ANOVA revealed a
significant main effect of Session and a significant Drug x Session interaction, Fs(27,324)
≥2.83, ps<0.001. The main effect of Drug was not significant, F(1,324)=2.05, p=0.178. In order
to further explore the interaction, paired-samples t-tests contrasted dipper entry rates from
amphetamine sessions with corresponding saline sessions. Notably, dipper entry rates differed
only on sessions 22 and 24, ts≥2.81, corrected ps≤0.03. CDP also evoked weak and unreliable
goal tracking (Figure 3B). Omnibus two-way ANOVA revealed a significant main effect of
Session, F(27,81)=7.30, p<0.001. The main effect of Drug, F(1,81)=4.60, p=0.064, and the
Drug x Session interaction, F(27,81)=1.08, p=0.362, were not significant. The present study
suggests that under conditions in which amphetamine and CDP serve as positive features
[28], and nicotine functions as a CS (Experiment 1, see also [4, 47]) CDP and amphetamine
do not function as interoceptive conditional stimuli and evoke goal tracking.
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Experiment 2B
Discrimination Training—Amphetamine does not evoke anticipatory food-seeking as the
result of pairings with sucrose (Experiment 2A), however under similar conditions it facilitates
anticipatory food-seeking evoked by discrete auditory and visual stimuli (Figure 4A, see also
[31]). The three-way ANOVA revealed significant main effects of Drug, F(1,247)=46.26,
p<0.001, and Session, F(19,247)=6.55, p<0.001, as well as a Drug x Session interaction, F
(19,247)=5.58, p<0.001. The main effect of CS, the Drug x CS interaction, Fs<1, and the Drug
x CS x Session interaction, F(19,247)=1.44, p=0.11, were not significant. However, the CS x
Session interaction was significant, F(19,247)=2.81, p<0.001.
Similar to amphetamine, CDP facilitates anticipatory food-seeking only when an interposed
stimulus is paired with the sucrose US. However, the topography of this goal tracking CR
depends on CS modality (Figures 4B and 4C). For elevation scores (Figure 4B), the three-way
ANOVA revealed that all main effects and interactions were significant, Fs≥3.02, ps≤0.017.
For rats receiving the light CS, mean elevation scores were significantly higher in the CDP
state relative to saline from sessions 3-20, ts(7)≥2.73, corrected ps≤0.03. However, for rats
receiving the white noise CS, CDP did not appear to facilitate anticipatory food-seeking; mean
elevation scores did not differ across drug states on any session, ts(7)≤1.70, ps≥0.133. Despite
a lack of drug state-specific goal tracking with the elevation score measure, a drug state-specific
CR was evident for rats receiving the white noise CS when the duration of dipper-entry
behaviors was measured (Figure 4C). The ANOVA revealed that only the main effects of Drug,
F(1,182)=59.98, p<0.001, and CS, F(1,14)=5.19, p=0.04, were significant. This “maintained
headpoke” conditional response was unsurprising given previous studies of goal tracking CRs
evoked by auditory CSs [9,15]. What was surprising was that the topography of conditional
responding interacted with drug state. Goal tracking frequency during auditory and visual cues
did not differ when rats were under the influence of psychomotor stimulants (AMP group, see
also Feature condition, Experiment 1). However, they did differ when rats were under the
influence of psychomotor depressants (CDP group). Future studies will be required to
determine how and whether stimulants prevented the “maintained headpoke” topography or
whether CDP may have exaggerated it.
Drug Extinction—During Drug Extinction, goal tracking evoked by drug (EXT groups) and
saline (RET groups) did not differ, confirming that amphetamine and CDP do not evoke a
conditional goal tracking response under the parameters employed in these studies. Mean
dipper entry rates for the AMP condition are presented in Figure 4D. The two-way ANOVA
revealed a significant main effect of Session, F(19,247)=4.79, p<0.001. The main effect of
Group and the Group x Session interaction were not significant, Fs≤1.27, ps≥0.29. Mean dipper
entry data for the CDP condition are presented in Figures 4E and 4F. The two-way ANOVA
for dipper entry rates (Figure 4E) revealed a significant main effect of Session, F(19,266)=3.82,
p<0.001. The main effect of Group, F<1, and the Group x Session interaction, F(19,266)=1.29,
p=0.19, were not significant. For dipper proportion (Figure 4F), there was a main effect of
Session, F(19,266)=6.07, p<0.001. The main effect of Group and the Group x Session
interaction were not significant, Fs<1.
Post-Extinction Tests—On the Post-Extinction Test, both EXT and RET groups displayed
more goal tracking during the CS on the drug session relative to the saline session (Figures 5A
& 5C). Thus, repeated presentation of the drug feature alone did not abolish its ability to
facilitate anticipatory food-seeking. The three-way ANOVA for the AMP condition revealed
a significant main effect of Drug, F(1,26)=17.76, p<0.001, and a significant Drug x Trial
interaction, F(2,26)=8.31, p<0.01. No other main effects or interactions were significant,
Fs≤1.49, ps≥0.24.
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For the CDP condition, the three-way ANOVA on elevation scores revealed that none of the
main effects or interactions were significant, Fs≤3.39, ps≥0.09. For duration scores, there was
a significant main effect of Drug, F(1,28)=48.64, p<0.001; with no other main effects or
interactions being significant, Fs≤1.59, ps≥0.22.
Discussion
One reason for investigating drug-states as occasion setters is their contextual nature. Drug
states are relatively enduring and therefore may be ‘on’ in the presence of many different
contexts, stimuli, and responses (any of which may be rewarding or aversive). This ubiquity
may bias them toward facilitative and/or inhibitory control over behavior by providing
information about relationships between contexts, stimuli, and responses/reinforcement. In the
present studies, the stimulus effects of nicotine, amphetamine, and CDP are experienced for
long periods without sucrose delivery (e.g., inter-trial intervals and any drug effect lasting after
the session). Thus, our working hypothesis has been that the drug states should facilitate goal
tracking in a manner that is independent of a direct association with sucrose. The present studies
support this hypothesis, the drug states facilitated goal-tracking behavior without having to be
directly associated with the goal stimulus. In Experiment 1, the interoceptive effects of nicotine
reliably evoked a goal-tracking response. Although the drug-extinction treatment attenuated
goal tracking that was directly evoked by nicotine, it had no effect on nicotine’s ability to
facilitate goal tracking when a discrete CS was presented in the nicotine-state. Although the
psychomotor stimulant effects of nicotine may have contributed to drug-evoked goal tracking,
extinction in the nicotine state eliminates this possibility. In Experiments 2A and 2B, there was
no evidence that amphetamine and CDP directly evoked a reliable goal tracking response.
Experiment 2A confirms that both drug states continue to facilitate responding to the CS even
after any latent excitatory influence had been abolished.
A second important finding that emerged during these studies was a different topography of
goal tracking evoked by the white noise CS in the CDP state, relative to other drug state-CS
combinations. Although this finding is somewhat surprising, a different topography does not
change the interpretation of the studies; if rats anticipate sucrose delivery, then they should
spend more time in the proximity of the goal area. By extension, they would be expected to
make dipper entries more frequently and with greater duration. Rats receiving CDP-white noise
combinations expressed a goal tracking CR that was not affected by CDP-extinction
(Experiment 2B); although the form of the CR was unexpected. We originally chose to measure
frequency based on previous studies [9], as well as preliminary studies which suggested this
measure adequately captured white noise-evoked goal tracking in both drug and no-drug
contexts [28; unpublished data]. However, other studies have shown that auditory stimuli
paired with sweet tastes tend to evoke a ‘maintained head-poke’ whereas visual stimuli tend
to evoke a higher frequency head-poke [10,16]. Farwell and Ayres [16] described more
frequent goal tracking with a visual CS as the result of both goal- and sign-tracking. Rats
alternated between goal seeking and ‘checking’ a light CS to determine its status (i.e., on or
off). They argued that the auditory CS did not evoke any ‘checking’ because it was detectable
when the subjects’ heads were in the receptacle. Related to this issue, Cleland and Davey
[11] found that auditory cues evoke more goal tracking, relative to visual cues, when paired
with food rewards. They argued that more sign tracking to the visual stimulus occurred because
rats were better able to localize its source. Finally, goal tracking topography may also be
affected by use of a discrete US (4-s dipper access) [16; present studies]. A temporally discrete
US would presumably make goal seeking temporally explicit and lead to CR topographies that
maximize the amount of time spent in the dipper during CS-offset/US-onset periods.
If auditory stimuli encourage a ‘maintained headpoke’, then why was this topography specific
to the CDP drug state in the present studies? As previously argued, many of the parameters of
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these studies should bias rats toward a sustained CR when auditory cues are used. In addition,
a depressant drug that reduces operant response-rate [15,36] might be expected to decrease
dipper entry rate. If there were no interference with goal tracking, then the sustained response
topography would be expected. Similarly, drugs that increase response rate and do not interfere
with goal seeking [i.e., nicotine, 42] might be expected to increase the frequency of dipper
entries, precluding the bias. Although this argument hinges on a preexisting and undetected
bias for a sustained response to the auditory cue, this bias is not without precedent [16]. In fact,
alternative accounts seem even less parsimonious. For example, one could argue that the CDP-
white noise combination predisposed rats to make drug-sucrose associations, and therefore rats
in this condition simply spent more time in the dipper receptacle. However, some of the many
problems with this argument include the discriminant nature of the duration score measure
(more goal tracking was still specific to the CS) and the lack of drug-evoked goal tracking after
acquisition (during drug-extinction). Further testing is required to determine if there was an
unobserved bias toward the sustained CR. If the psychomotor suppressant effects of CDP
exposed this bias, then other psychomotor suppressants would be expected to induce the same
topography of goal tracking with an auditory CS.
A second unexpected finding was that nicotine directly evoked goal tracking, but amphetamine
and CDP did not. Although the study that directly tested whether these drugs would evoke goal
tracking (Experiment 2A) had a relatively small sample size, the finding was corroborated by
Experiment 2B in which the drug state did not evoke goal tracking during the extinction phase.
Although we cannot determine whether associations were made between the drug states and
sucrose, we can reasonably conclude that such associations did not contribute to the goal
tracking CR. This conclusion prompts a number of interesting questions about why
amphetamine and CDP do not directly evoke goal seeking responses, whereas nicotine did
evoke anticipatory food seeking behavior that was susceptible to extinction. Do the effects of
these two drugs overshadow the sucrose reward or interfere with the goal tracking response?
Unlikely, given that these accounts also make the prediction that amphetamine and CDP would
not facilitate CRs evoked by a discrete stimulus (cf. Experiment 2B). In other unpublished
studies we have manipulated various parameters including the use of less reinforcing drug
states (e.g., caffeine), different drug doses (e.g., 0.5 mg/kg amphetamine), and more frequent
sucrose deliveries (e.g., 36 deliveries in 20 min). At this time, nicotine is the only drug state
which reliably evokes anticipatory food seeking [4,47]. Future studies should determine what
features of nicotine make it relatively unique in this regard, or determine the necessary
conditions to establish other drugs as interoceptive CSs. For example, do rats fail to make
associations between these other drug states and the sucrose US? Is a longer session necessary
due to pharmacokinetic or pharmacodynamic reasons? Why are these drugs able to facilitate
responding to discrete cues despite their inability to directly evoke anticipatory food seeking?
In the present studies nicotine, amphetamine, and CDP facilitated goal tracking and this
facilitation did not depend on direct associations between the drug state and the goal stimulus.
Preliminary evidence [26] suggests that these drug states will also transfer their facilitative
control over responding to novel situations. Together, these two findings suggest that the drug
states may influence goal tracking via hierarchical or non-associative processes, similar to other
Pavlovian occasion setters [44]. Returning to our earlier example, a drug state that previously
set the occasion for pairings between a discrete stimulus and smoking could also facilitate
conditional responses (craving, tobacco seeking, etc.) when a new smoking-related stimulus
occurs in that context. Moreover, extinguishing the drug context would not be sufficient to
eliminate its facilitative control. This offers a complex set of challenges to exposure therapies
[5]. Evidence from the associative learning literature suggests that eliminating facilitation by
occasion setters requires the original feature-CS combination to be extinguished [23]. Although
such extensive exposure may not be realistic in the clinical setting, both the recipients and
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providers of these treatments should be wary of ‘drug contexts’ and how they may influence
the meaning of stimuli and responses as hindrances to treatment or inducers of relapse.
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Figure 1.
(A) Mean elevation scores (±1 SEM) from discrimination training for rats in the Feature
condition receiving the light or white noise target CS. (B) Mean dipper entry rates (±1 SEM)
from discrimination training for rats in the CS condition. Mean dipper entry rates for EXT and
RET groups during the drug extinction phase for rats in the Feature (C) and CS (D) conditions,
respectively. + indicates elevation score for rats receiving the white noise CS differs
significantly from rats receiving the light CS in the nicotine state, p<0.05. # indicates elevation
score for rats receiving the white noise CS differs significantly from rats receiving the light
CS in the saline state, p<0.05. * indicates dipper entry rate on drug session significantly differs
from responding on corresponding saline session (B), or dipper entry for EXT group
significantly differs from RET group (C & D), p<0.05.
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Figure 2.
(A) Mean elevation scores (±1 SEM) from the post-extinction test for rats in the Feature
condition. For comparative purposes, baselines are included in the left-hand portion of the
graph. These data points represent mean elevation scores from the first trial of the last nicotine
and saline sessions for each group from Discrimination Training. Filled symbols represent
elevation scores from nicotine trials, open symbols represent elevation scores from saline test
trials. (B) Mean dipper entry rates (±1 SEM) from the post-extinction test for rats in the CS
condition. Baselines are included in the left-hand portion of the graph; these data points
represent means for each measure from the last nicotine and saline sessions of Discrimination
Training. * indicates dipper entry rate on drug session differed significantly from dipper entry
rate on saline session, p<0.05.
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Figure 3.
(A) Mean dipper entry rates (±1 SEM) from the Discrimination Training phase for rats in the
Amphetamine group. (B) Mean dipper entry rates (±1 SEM) from the Discrimination Training
phase for rats in the Chlordiazepoxide (CDP) group.
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Figure 4.
(A) Mean elevation scores (±1 SEM) from the discrimination training phase for rats in the
AMP condition. (B) Mean elevation scores (±1 SEM) from the discrimination training phase
for rats in the CDP condition. (C) Mean duration scores (±1 SEM) from the discrimination
training phase for rats in the CDP condition. (D) Mean dipper entry rates (±1 SEM) from the
drug extinction phase for EXT and RET groups from the AMP condition. (E) Mean dipper
entry rates (±1 SEM) from the drug extinction phase for EXT and RET groups from the CDP
condition. (F) Mean dipper entry proportions (±1 SEM) from the drug extinction phase for
EXT and RET groups from the CDP condition.
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Figure 5.
(A) Mean elevation scores (±1 SEM) for EXT and RET groups from the post-extinction test
for rats in the AMP condition of Experiment 2B. (B) Mean elevation scores (±1 SEM) for EXT
and RET groups from the post-extinction test for rats in the CDP condition. (C) Mean duration
scores (±1 SEM) for EXT and RET groups from the post-extinction test for rats in the CDP
condition. Filled symbols represent elevation or duration scores from drug test trials, open
symbols represent elevation or duration scores from saline test trials. Baselines are included
in the left-hand portion of each panel; these data points represent mean elevation scores from
the first trial of the last drug and saline sessions from the Discrimination Training phase.
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